Discontinuation of statin therapy in patients with normal cholesterol
Pro Research Analysisby 
Searched over 200M research papers
Statin Therapy Discontinuation: Prevalence and Patient Characteristics
Discontinuation of statin therapy is common, with studies showing that between 40% and 75% of patients stop taking their statins within the first year of treatment, regardless of their cholesterol levels at the start of therapy Banach20164Zhu2021. Many patients who discontinue statins eventually restart them, but a significant portion remain off therapy, especially among younger and older adults, women, and those with chronic liver disease .
Reasons for Discontinuing Statins in Patients with Normal Cholesterol
The most frequently reported reasons for discontinuing statin therapy are concerns about side effects, particularly muscle symptoms, and the perception that statins are not safe or effective Ward2019Dicken2022Bradley2019. Fear of side effects and actual experiences of muscle pain or weakness are the leading causes cited by patients, even when their cholesterol levels are normal or well-controlled Ward2019Dicken2022Bradley2019. Additionally, some patients discontinue statins because they believe their cholesterol is now normal and that continued therapy is unnecessary .
Impact of Statin Discontinuation on Cholesterol and Cardiovascular Risk
Discontinuing statin therapy leads to a rapid and significant increase in blood cholesterol levels. Research shows that within just four days of stopping statins, LDL cholesterol, total cholesterol, and triglycerides can rise sharply, with levels peaking within two weeks and returning to pre-treatment values . This increase occurs regardless of how long the patient was on statins or the dose used . As a result, stopping statins—even in patients with previously normal cholesterol—removes the protective effect against cardiovascular disease, increasing the risk of heart attacks and strokes Banach2016Ward2019Alvarez-Jimenez2024.
Patient Beliefs and Willingness to Restart Statins
Many patients who discontinue statins due to side effects or concerns about safety are still open to restarting therapy if their concerns are addressed . Education about the benefits and safety of statins, as well as careful management of side effects, can help improve adherence and reduce unnecessary discontinuation Dicken2022Bradley2019.
Conclusion
Discontinuation of statin therapy is widespread, often driven by concerns about side effects and the belief that normal cholesterol levels mean ongoing treatment is unnecessary. However, stopping statins leads to a quick rise in cholesterol and increased cardiovascular risk. Addressing patient concerns and providing clear information about the benefits and safety of statins can help improve adherence and protect long-term heart health Banach2016Ward2019Dicken2022+2 MORE.
Sources and full results
Most relevant research papers on this topic